Skinvisible (SKVI) EBIT Growth (5y) (2015 - 2026)
Powered by 
Analysis
Skinvisible (SKVI) EBIT Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.04% |
| Mar 31, 2026 | -2.53% |
| Dec 31, 2025 | -75.83% |
| Sep 30, 2025 | 2.21% |
| Jun 30, 2025 | -60.57% |
| Mar 31, 2025 | -1.47% |
| Dec 31, 2024 | -11.09% |
| Sep 30, 2024 | 1.81% |
| Jun 30, 2024 | -0.48% |
| Mar 31, 2024 | 3.35% |
| Dec 31, 2023 | 2.31% |
| Sep 30, 2023 | 3.99% |
| Jun 30, 2023 | 2.99% |
| Mar 31, 2023 | 6.03% |
| Dec 31, 2022 | -19.92% |
| Sep 30, 2022 | 2.13% |
| Jun 30, 2022 | 17.86% |
| Mar 31, 2022 | 12.40% |
| Dec 31, 2021 | 24.27% |
| Sep 30, 2021 | 47.75% |